lncRNA H19 can promote the development of bronchopulmonary dysplasia by regulating the MAPK signaling pathway, and the MAPK signaling pathway can be used as a potential target for the treatment of bronchopulmonary dysplasia [16]. Here, H19 is linked to bronchopulmonary dysplasia.